FDA
approval
· 2019-08-29
FDA Approved: ASCLERA — Supplemental Application (Methapharm, Inc)
Summary
FDA approved a supplemental application for ASCLERA (polidocanol) from Methapharm, Inc. The approval updates regulation around the product, which is used as a s…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ASCLERA (POLIDOCANOL)